GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Deferred Tax

Oxygenta Pharmaceutical (BOM:524636) Deferred Tax : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Oxygenta Pharmaceutical's change in deferred tax for the three months ended in Mar. 2024 was ₹0.0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.0 Mil.

Oxygenta Pharmaceutical Deferred Tax Historical Data

The historical data trend for Oxygenta Pharmaceutical's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Deferred Tax Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oxygenta Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oxygenta Pharmaceutical Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxygenta Pharmaceutical Deferred Tax Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxygenta Pharmaceutical (BOM:524636) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Deferred Tax
Comparable Companies
BOM:524652 BOM:542934 BOM:539938 BOM:540694 BOM:538964 BOM:524396 BOM:524202 BOM:506128 BOM:524572 BOM:530233 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032
Website
http://oxygentapharma.com
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines